🔎 Trials Near Me

ホーム › 肥満症 › ペンシルベニア › Philadelphia

Philadelphia、PAにおける肥満症の臨床試験

Philadelphiaとその周辺地域(約30マイル以内)の拠点で、肥満症に関する23件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

被験者募集中第2相
  • Suburban Research Associates, West Chester · 24マイル先
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

被験者募集中第3相
  • Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

被験者募集中第3相
  • Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

被験者募集中第3相
  • UPA Ctr Weight and Eating Dis, Philadelphia
18歳以上 · 全性別 · 2026/09/24更新 · NCT07339423

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

被験者募集中第3相
  • Abington Medical Specialists, Horsham · 16マイル先
  • Family Practice Associates, Wilmington · 25マイル先
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

被験者募集中第3相
  • Keystone Clinical Studies, Plymouth Meeting · 12マイル先
18歳以上 · 全性別 · 2026/09/22更新 · NCT07353931

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

被験者募集中第3相
  • AURORA-1 Clinical Site, Philadelphia
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

被験者募集中第3相
  • AURORA-2 Clinical Site, Philadelphia
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

被験者募集中第3相
  • Abington Medical Specialists, Horsham · 16マイル先
18歳〜99歳 · 全性別 · 2026/09/16更新 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

被験者募集中第3相
  • Suburban Research Associates - West Chester Office, West Chester · 24マイル先
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

被験者募集中第3相健康なボランティア歓迎
  • ACCOMPLISH-2 Research Site, Philadelphia
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

被験者募集中第3相
  • UPA Ctr Weight and Eating Dis, Philadelphia
18歳以上 · 全性別 · 2026/09/09更新 · NCT07770841

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

被験者募集中第4相
  • Dermatology Associates of Plymouth Meeting, Plymouth Meeting · 12マイル先
18歳以上 · 全性別 · 2026/09/04更新 · NCT06857942

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

被験者募集中第3相
  • Research Site, Philadelphia
18歳以上 · 全性別 · 2026/08/25更新 · NCT07784725

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

被験者募集中第2相
  • Children's Hospital of Philadelphia, Philadelphia
7歳〜25歳 · 全性別 · 2026/08/19更新 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

被験者募集中第3相
  • Thomas Jefferson University, Philadelphia
18歳以上 · 全性別 · 2026/08/18更新 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

被験者募集中第3相
  • ACCOMPLISH-1 Research Site, Philadelphia
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361

An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents

被験者募集中健康なボランティア歓迎
  • Drexel University, Philadelphia
14歳〜19歳 · 女性 · 2026/07/20更新 · NCT06147973

Weight Bias Reducation Intervention With Nursing Students Using Simulation: The BRAVE Study

被験者募集中
  • Villanova University, Villanova · 11マイル先
18歳〜35歳 · 全性別 · 2026/07/17更新 · NCT07334470

A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program

被験者募集中
  • Drexel University, Philadelphia
  • University of Pennsylvania, Philadelphia
25歳〜59歳 · 全性別 · 2026/06/12更新 · NCT05748158

Optimizing a Mobile Health Platform for Sleep Promotion and Obesity Prevention in Children

被験者募集中健康なボランティア歓迎
  • Children's Hospital of Philadelphia, Philadelphia
8歳〜12歳 · 全性別 · 2026/05/27更新 · NCT05703347

Feasibility of Semaglutide in Advanced Lung Disease

被験者募集中第1/2相
  • University of Pennsylvania Perelman School of Medicine, Philadelphia
18歳〜80歳 · 全性別 · 2026/04/21更新 · NCT05746039

RemI for Post-Bariatric Surgery Weight Regain

被験者募集中健康なボランティア歓迎
  • Temple University, Philadelphia
18歳〜70歳 · 全性別 · 2026/04/03更新 · NCT06292936

他の都市における肥満症の試験

Philadelphiaにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。